ARCHIVES

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

This article is from The Cancer Letter archive.

Vol. 17 No. 45 | November 22, 1991

Download PDF Visit The Full Archive

Related Articles

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

Clarification: Full Text Of ACS Guideline On Prostate Screening

January 30, 1998

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981